Article Versions Notes

Yared W, Dogan L, Fassli AM, Moza A, Goetzenich A, Stoppe C, Mohammed AFA, Kraemer S, Tewarie L, Abugameh A, et al. Fibroblast Growth Factor 23 Is a Strong Predictor of Adverse Events After Left Ventricular Assist Device Implantation. Journal of Cardiovascular Development and Disease. 2025; 12(8):290. https://doi.org/10.3390/jcdd12080290

Yared, Wissam, Leyla Dogan, Ahsannullah Madad Fassli, Ajay Moza, Andreas Goetzenich, Christian Stoppe, Ahmed F. A. Mohammed, Sandra Kraemer, Lachmandath Tewarie, Ahmad Abugameh, and et al. 2025. "Fibroblast Growth Factor 23 Is a Strong Predictor of Adverse Events After Left Ventricular Assist Device Implantation" Journal of Cardiovascular Development and Disease 12, no. 8: 290. https://doi.org/10.3390/jcdd12080290

Yared, W., Dogan, L., Fassli, A. M., Moza, A., Goetzenich, A., Stoppe, C., Mohammed, A. F. A., Kraemer, S., Tewarie, L., Abugameh, A., & Zayat, R. (2025). Fibroblast Growth Factor 23 Is a Strong Predictor of Adverse Events After Left Ventricular Assist Device Implantation. Journal of Cardiovascular Development and Disease, 12(8), 290. https://doi.org/10.3390/jcdd12080290